Edition:
India

Dechra Pharmaceuticals PLC (DECP.L)

DECP.L on London Stock Exchange

1,269.00GBp
22 Jul 2016
Change (% chg)

13.00p (+1.03%)
Prev Close
1,256.00p
Open
1,258.00p
Day's High
1,274.00p
Day's Low
1,250.00p
Volume
69,579
Avg. Vol
204,602
52-wk High
1,274.00p
52-wk Low
811.00p

DECP.L

Chart for DECP.L

About

Dechra Pharmaceuticals PLC is a veterinary pharmaceuticals company. The Company is engaged in the development, manufacture and marketing of products for veterinarians across the world. The Company's segments include European Pharmaceuticals, consists of Dechra Veterinary Products EU and Dechra Pharmaceuticals Manufacturing;... (more)

Overall

Beta: 0.23
Market Cap(Mil.): £1,176.96
Shares Outstanding(Mil.): 92.75
Dividend: 5.55
Yield (%): --

Financials

  DECP.L Industry Sector
P/E (TTM): 55.30 36.05 37.00
EPS (TTM): 0.23 -- --
ROI: 7.33 14.84 14.11
ROE: 10.04 15.93 15.34

BRIEF-Dechra names Tony Rice as chairman from October

* Tony rice has been appointed to board as non-executive director and will be appointed as chairman with effect from conclusion of company's annual general meeting on 21 october 2016 Source text for Eikon: Further company coverage: (Reporting By UK Bureau)

08 Apr 2016

BRIEF-Dechra Pharmaceuticals buys Putney Inc for $200 mln

* Proposed £48.4 million placing of new ordinary shares at 1100 pence per share

15 Mar 2016

BRIEF-Dechra Pharma CFO steps down to join Merlin

* chief financial officer, anne-francoise nesmes, will be stepping down from board of dechra Source text for Eikon: Further company coverage: (Reporting By London Bureau)

16 Feb 2016

Earnings vs. Estimates